U.S. Markets closed

Praxair, Inc. (PX)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
136.51+1.77 (+1.31%)
At close: 4:03PM EDT

136.51 0.00 (0.00%)
After hours: 4:45PM EDT

People also watch
APDPPGECLITWPH
Full screen
Previous Close134.74
Open135.07
Bid96.13 x 100
Ask136.50 x 100
Day's Range134.66 - 136.58
52 Week Range114.43 - 138.69
Volume2,031,905
Avg. Volume1,141,401
Market Cap39.05B
Beta1.09
PE Ratio (TTM)25.56
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield3.15 (2.35%)
Ex-Dividend Date2017-09-07
1y Target EstN/A
Trade prices are not sourced from all markets
  • Reuters9 hours ago

    UPDATE 1-Norway's $1 trillion wealth fund backs Linde-Praxair deal

    The proposed $74 billion tie-up of German industrial gases group Linde and U.S. peer Praxair got a boost on Tuesday when the world's biggest sovereign wealth fund said it was backing the deal. The Norwegian fund, which also said the value of its assets had topped $1 trillion, will vote in favour of four key resolutions proposed by Praxair's management at a Sept. 27 meeting of shareholders, it said. "We support the strategic rationale for the merger ... the proposed business combination is in the best long-term interest of Linde AG shareholders," Norges Banks Investment Management (NBIM), which manages the fund, said in a statement.

  • Reuters10 hours ago

    Linde could lower threshold for Praxair exchange offer -Euro magazine

    German industrial gases group Linde does not rule out lowering the shareholder acceptance threshold for its planned $75 billion merger with U.S. peer Praxair, its chief executive told German magazine Euro. Linde shareholders have until Oct. 24 to exchange their Linde shares for shares in the new, combined company. An acceptance rate of 75 percent has been set for the merger to go through.

  • Mallinckrodt Down as District Court Invalidates Inomax Patents
    Zacks13 days ago

    Mallinckrodt Down as District Court Invalidates Inomax Patents

    Shares of Mallinckrodt plc (MNK) were down 12.3% after a U.S. District Court invalidated 11 patents covering its second-largest product Inomax.